Science Speaks continues its interview series exploring the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a conversation with Bess Miller, MD, MSc, who works in the Division of Global HIV/AIDS. Dr. Miller has served as associate director and team lead for HIV/TB, providing leadership in policy and implementation of TB/HIV activities in 43 resource-limited countries supported by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). She has worked to align PEPFAR TB/HIV priorities with the World Health Organization (WHO) policies on TB/HIV, and on the use of antiretroviral therapy (ART) in people living with HIV (PLHIV). In this interview Dr. Miller discusses the successes and challenges in implementing TB infection control in Africa, progress in deploying the GeneXpert MTB/RIF rapid TB diagnostic on the ground there, and how efforts to scale up access to ART are helping achieve goals in TB control and elimination.
White House proposals to slash more than a billion dollars from U.S. supported HIV responses and limit efforts to control the epidemic to a handful of […]
Researchers at the University of Cape Town in South Africa have identified a sequence of biological processes that occur as tuberculosis infection progresses to active pulmonary […]
In time for meetings of international leaders, 2016 boost in TB investments sets new — but low — bar, as well as impetus to gain on […]
Ebola stories highlight global health security needs, efforts, progress in emerging infections detection, prevention, response
In 2014, as international health leaders and policy makers launched the Global Health Security Agenda to meet increasingly urgent needs to prevent, detect and respond to […]